Trial intelligence / Profile preview

Safety and Immunogenicity of Shanchol in Dominican Republic

NCT02434822Phase 3Completed

Sponsor
Sanofi
Start
Apr 2015
Primary completion
Sep 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of cholera vaccine (inactivated, oral) in cholera, sponsored by Sanofi. Started Apr 2015; status: completed.

02

Drugs

cholera vaccine (inactivated, oral)
03

Conditions

cholera

Beyond the preview

Go deeper on NCT02434822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02434822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call